[Multicenter clinical trial on the efficacy of thrombolytic therapy with urokinase and/or anticoagulant with low molecular weight heparin in acute pulmonary embolism].

@article{Cheng2002MulticenterCT,
  title={[Multicenter clinical trial on the efficacy of thrombolytic therapy with urokinase and/or anticoagulant with low molecular weight heparin in acute pulmonary embolism].},
  author={Xian-sheng Cheng and Jianguo He and M. Gao and Guangjin Chen and Shuhua Li and Zhonghe Zhang and Mingwu Zhao and Sumin Zhou and Jiwen Zhao and Lizhu Cheng and Zhenxiang Zhang and Yulin Chen and Chang-ming Xiong},
  journal={Zhonghua nei ke za zhi},
  year={2002},
  volume={41 1},
  pages={6-10}
}
OBJECTIVE To evaluate the efficacy of thrombolytic therapy with urokinase and/or anticoagulant with low molecular weight heparin in patients with acute pulmonary embolism. METHODS 127 patients with documented acute pulmonary embolism were treated with different regimens: thrombolysis combined with anticoagulant therapy in 70 cases, thrombolytic therapy alone in 31 cases and pure anticoagulant therapy in 26 cases. RESULTS Dyspnea was the most common symptom (91.3%), then cough (74.0%), chest… CONTINUE READING